01 mars 2012

Riemser invests in Anwerina

RIEMSER Arzneimittel AG invests in anwerina AG, a life science company specialized in the development and marketing of innovative orthopedic pharmaceutical and medical products. VISCHER advises anwerina AG in the transaction. The team is led by partner Benedict F. Christ.

Partager l'article sur :

Service(s) inclus :

Contactez nos autrices et auteurs et bénéficiez de leur expertise:

partner-Benedict F.-0

Benedict F. Christ

benedict.christ@vischer.com

+41 58 211 34 62

Notre
newsletter

Riemser invests in Anwerina